Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tsutomu Imaizumi

Showing results (1-10 of 231) with videos related to

Pageof 24
Sort By:
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 29, 2005
Special report from the heart transplant candidate registry committee in JapanKatsunori Osada, Tsutomu Imaizumi,
Clinical Calcium|October 4, 2005
[Calcium antagonists and ischemic heart disease]Hidehiro Matsuoka, Tsutomu Imaizumi
Nippon Ganka Gakkai Zasshi|July 29, 2005
[Molecular mechanism of diabetic retinopathy: role of advanced glycation end products(AGEs) and their receptor (RAGE) in the pathogenesis of diabetic retinopathy]Sho-ichi Yamagishi, Tsutomu Imaizumi
Current Pharmaceutical Design|July 19, 2005
Diabetic vascular complications: pathophysiology, biochemical basis and potential therapeutic strategySho-ichi Yamagishi, Tsutomu Imaizumi
Hypertension Research : Official Journal of the Japanese Society of Hypertension|March 9, 2012
Losartan/hydrochlorothiazide combination vs. high-dose losartan in patients with morning hypertension--a prospective, randomized, open-labeled, parallel-group, multicenter trialTamenobu Ueda, Hisashi Kai, Tsutomu Imaizumi, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 5, 2008
[Gene therapy and cell therapy for idiopathic pulmonary arterial hypertension]Kiyoko Takemiya, Hisashi Kai, Tsutomu Imaizumi
Current Diabetes Reviews|January 29, 2008
Advanced glycation end products (AGEs) and diabetic vascular complicationsSho-ichi Yamagishi, Kazuo Nakamura, Tsutomu Imaizumi
Hypertension Research : Official Journal of the Japanese Society of Hypertension|October 20, 2005
Diastolic dysfunction in hypertensive hearts: roles of perivascular inflammation and reactive myocardial fibrosisHisashi Kai, Fumitaka Kuwahara, Keisuke Tokuda, et al.
JAK-STAT|September 24, 2013
SOCS3: A novel therapeutic target for cardioprotectionHideo Yasukawa, Takanobu Nagata, Toyoharu Oba, et al.
Journal of Cardiovascular Pharmacology|February 12, 2004
Sub-depressor dose of angiotensin type-1 receptor blocker inhibits transforming growth factor-beta-mediated perivascular fibrosis in hypertensive rat heartsKeisuke Tokuda, Hisashi Kai, Fumitaka Kuwahara, et al.
Pageof 24

Showing results (1-10 of 231) with videos related to

Sort By:
Pageof 24
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 29, 2005
Special report from the heart transplant candidate registry committee in JapanKatsunori Osada, Tsutomu Imaizumi,
Clinical Calcium|October 4, 2005
[Calcium antagonists and ischemic heart disease]Hidehiro Matsuoka, Tsutomu Imaizumi
Nippon Ganka Gakkai Zasshi|July 29, 2005
[Molecular mechanism of diabetic retinopathy: role of advanced glycation end products(AGEs) and their receptor (RAGE) in the pathogenesis of diabetic retinopathy]Sho-ichi Yamagishi, Tsutomu Imaizumi
Current Pharmaceutical Design|July 19, 2005
Diabetic vascular complications: pathophysiology, biochemical basis and potential therapeutic strategySho-ichi Yamagishi, Tsutomu Imaizumi
Hypertension Research : Official Journal of the Japanese Society of Hypertension|March 9, 2012
Losartan/hydrochlorothiazide combination vs. high-dose losartan in patients with morning hypertension--a prospective, randomized, open-labeled, parallel-group, multicenter trialTamenobu Ueda, Hisashi Kai, Tsutomu Imaizumi, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 5, 2008
[Gene therapy and cell therapy for idiopathic pulmonary arterial hypertension]Kiyoko Takemiya, Hisashi Kai, Tsutomu Imaizumi
Current Diabetes Reviews|January 29, 2008
Advanced glycation end products (AGEs) and diabetic vascular complicationsSho-ichi Yamagishi, Kazuo Nakamura, Tsutomu Imaizumi
Hypertension Research : Official Journal of the Japanese Society of Hypertension|October 20, 2005
Diastolic dysfunction in hypertensive hearts: roles of perivascular inflammation and reactive myocardial fibrosisHisashi Kai, Fumitaka Kuwahara, Keisuke Tokuda, et al.
JAK-STAT|September 24, 2013
SOCS3: A novel therapeutic target for cardioprotectionHideo Yasukawa, Takanobu Nagata, Toyoharu Oba, et al.
Journal of Cardiovascular Pharmacology|February 12, 2004
Sub-depressor dose of angiotensin type-1 receptor blocker inhibits transforming growth factor-beta-mediated perivascular fibrosis in hypertensive rat heartsKeisuke Tokuda, Hisashi Kai, Fumitaka Kuwahara, et al.
Pageof 24